A recent study reveals a concerning disparity in access to diabetes technology among ethnic minorities in England. Despite being more prone to diabetes, these communities face barriers to obtaining essential devices like continuous glucose monitors (CGMs).
The research, published in Diabetic Medicine, highlights a stark contrast in prescribing rates. Black and South Asian individuals, who are at a higher risk of type 2 diabetes, have lower CGM prescribing rates compared to the general population. This discrepancy is particularly alarming as it contributes to a cycle of health disparities.
Samuel Seidu, a professor at the University of Leicester, emphasizes the gravity of the situation. He states, 'The disparity is not entirely surprising, although it is concerning as previous research internationally (especially in the US) has repeatedly shown lower adoption of diabetes technologies in minority ethnic groups.'
The study underscores the impact of structural inequities in healthcare access. Ethnicity and deprivation together account for up to 77% of the variance in CGM prescribing for type 2 diabetes. This means that systemic issues are deeply ingrained in the healthcare system, making it challenging for certain communities to access life-changing technology.
According to National Institute for Health and Care Excellence (NICE) guidelines, all adults with diabetes should have access to CGMs. However, the study reveals a discrepancy in implementation. Anthony Walker, policy lead at Diabetes UK, highlights the need for active awareness-raising and support for healthcare professionals to address these inequities.
The situation is further complicated by the fact that many families from deprived backgrounds struggle to utilize NHS-provided technology due to the cost of smartphones, which are essential for managing type 1 diabetes, especially in children. This creates a cycle of disadvantage, where access to technology is determined by factors beyond clinical need.
Diabetes advocate Daniel Newman, who was diagnosed with type 1 diabetes as a child, emphasizes the importance of equitable access to CGMs. He states, 'Access to CGMs should be based on clinical need, not determined by postcode, ethnicity, or income.'
The study calls for urgent action to address these disparities, ensuring that NICE guidelines are not just acknowledged but actively implemented to benefit all eligible individuals, regardless of their background.
